BeOne Medicines Ltd. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
ONC on Nasdaq, BEIGF on OTC
Location
Basel
Fiscal year end
31 December
Latest financial report
26 Feb 2026

Quick Takeaways

  • ONC - BeOne Medicines Ltd. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 7.5%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-140%</span>.
  • Most recent SEC facts end date: 13 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-13) highlights Return On Equity 7.5%, Return On Assets 4.1%, and Operating Margin 8.4%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

45.3/100

Caution Confidence medium

Return On Equity

7.5%

Metric score 0.0/100

Return On Assets

4.1%

Metric score 25.8/100

Financial Health

Current Ratio
3.41x
Quick Ratio
2.96x
Debt to Equity
0.77x

Strengths

Debt-to-equity and Revenues YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

7.5%

YoY: -140%

Industry median: -43% (n=675)

View history

Return On Assets

4.1%

YoY: -137%

Industry median: -47% (n=673)

View history

Operating Margin

8.4%

YoY: -156%

Industry median: -121% (n=298)

View history

Current Ratio

3.41x

YoY: +89%

Industry median: 3.39x (n=667)

View history

Quick Ratio

2.96x

YoY: +98%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

0.77x

YoY: +8.4%

Industry median: 0.26x (n=530)

View history

Revenues YoY

40%

YoY:

Industry median: 7.3% (n=302)

View history

Profitability

Metric Latest value YoY change
Return On Equity 7.5% -140%
Return On Assets 4.1% -137%
Operating Margin 8.4% -156%

Financial Health

Metric Latest value YoY change
Current Ratio 3.41x +89%
Quick Ratio 2.96x +98%
Debt-to-equity 0.77x +8.4%

Growth

Metric Latest value YoY change
Revenues YoY 40%
Net Income (Loss) Attributable to Parent $286,933,000

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 1,442,259,810 +4%
Common Stock, Shares, Outstanding 1,441,075,618 +3.9%
Common Stock, Value, Issued $144,000 +4.3%
Weighted Average Number of Shares Outstanding, Basic 1,417,803,727 +3.6%
Weighted Average Number of Shares Outstanding, Diluted 1,474,829,908 +7.8%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $5,343,033,000 +40%
Research and Development Expense $2,145,868,000 +9.9%
Costs and Expenses $4,227,357,000 +12%
Operating Income (Loss) $447,136,000
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $416,854,000
Income Tax Expense (Benefit) $129,921,000 +16%
Earnings Per Share, Basic 0.2
Earnings Per Share, Diluted 0.19
Cash and Cash Equivalents, at Carrying Value $4,547,530,000 +73%
Accounts Receivable, after Allowance for Credit Loss, Current $865,080,000 +28%
Inventory, Net $608,227,000 +23%
Assets, Current $6,233,589,000 +56%
Property, Plant and Equipment, Net $1,641,678,000 +4%
Operating Lease, Right-of-Use Asset $148,184,000 +6.4%
Other Assets, Noncurrent $102,418,000 -36%
Assets $8,188,573,000 +38%
Accounts Payable, Current $479,035,000 +18%
Employee-related Liabilities, Current $305,055,000 +23%
Accrued Liabilities, Current $1,109,120,000 +38%
Liabilities, Current $1,828,830,000 -17%
Deferred Income Tax Liabilities, Net $53,209,000 +27%
Operating Lease, Liability, Noncurrent $52,940,000 +20%
Other Liabilities, Noncurrent $80,245,000 +20%
Liabilities $3,827,379,000 +48%
Accumulated Other Comprehensive Income (Loss), Net of Tax $78,184,000 +48%
Retained Earnings (Accumulated Deficit) $8,319,903,000 +3.3%
Stockholders' Equity Attributable to Parent $4,361,194,000 +31%
Liabilities and Equity $8,188,573,000 +38%
Common Stock, Shares, Issued 1,540,975,898 +11%
Common Stock, Par or Stated Value Per Share 0.0001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,609,647,000 +75%
Deferred Tax Assets, Valuation Allowance $3,648,017,000 +7.2%
Deferred Tax Assets, Gross $3,692,017,000 +8.3%
Operating Lease, Liability $73,638,000 +19%
Depreciation $131,615,000 -21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $357,737,000
Lessee, Operating Lease, Liability, to be Paid $80,569,000 +18%
Property, Plant and Equipment, Gross $2,043,214,000 +54%
Operating Lease, Liability, Current $20,698,000 +18%
Lessee, Operating Lease, Liability, to be Paid, Year Two $21,761,000 +64%
Lessee, Operating Lease, Liability, to be Paid, Year One $23,653,000 +19%
Operating Lease, Weighted Average Discount Rate, Percent 0.0502 -4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,931,000 +3.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three $16,453,000 +31%
Unrecognized Tax Benefits $27,835,000 +61%
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,173,000 -4.8%
Additional Paid in Capital $12,759,137,000 +5.6%
Amortization of Intangible Assets $10,071,000 +109%
Share-based Payment Arrangement, Expense $510,247,000 +15%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY